RE: RE: RE: RE: takeover/control BNCAre you kidding? $2.00 to $2.50 for a company witha product in the pipeline worth at least a billion world wide. Lads be patient Uricidin is for real. ENDO are not idiots, you don't need all the Is dotted and Ts crossed to know if the product is effective. We already know that it is safe. ENDO has preliminary data in hand. For them to sign for the world, they are reasonably sure that it is effective thus far. This talk about a silly buyout is too preliminary. This product has every chance of restricted use in refractory cases after the completion of the current PIII. Full approval after the second PIII fast tracked. Hold on and we'll see $3.00 to $5.00 in 6 months. It would already be there if this was an US company. Check out what happened to Athersys in short order and we are way ahead of them.